Transparency Market

Research
Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis,
Size, Share, Growth, Trends and Forecast 2015 - 2023

Published Date
29-Jan-2016

100 Page Report

Buy Now

Request Sample

Press Release

Inhalation and Nasal Spray Generic Drugs Market Expected to Reach

US$35.5 bn Globally by 2023

Transparency Market Research

State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com

Inhalation and Nasal Spray

Generic Drugs Market

REPORT DESCRIPTION

Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast 2015 - 2023
According to a new market report published by Transparency Market Research Inhalation and Nasal Spray
Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 the
global inhalation and nasal spray generic drugs market was valued at US$21.8 bn in 2014 and is estimated
to reach US$35.5 bn by 2023 at a CAGR of 5.5% from 2015 to 2023.
Browse Full Report with TOC:
http://www.transparencymarketresearch.com/inhalation-nasal-spray-generic-drugs.html
This report on the inhalation and nasal spray generic drugs market studies the current and future
prospects of the global market. Growing incidences of respiratory diseases such as asthma and COPD,
increasing geriatric population, and increasing number of generic manufacturers is expected to accentuate
the growth of inhalation and nasal spray generic drugs market globally. The inhalation and nasal spray
generic drugs market report comprises an elaborate executive summary, which includes a market
snapshot that provides information about various segments and sub-segments of the market. It also
provides information and data analysis of the global inhalation and nasal spray generic drugs market with
respect to market segments based on drug class, medical indication and their geographic analysis.
Based on drug class, the inhalation and nasal spray generic drugs market has been segmented into five
major categories: corticosteroids, bronchodilators, antihistamines, combinations, and decongestant sprays.
The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and
geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been
provided for the period from 2013 to 2023. The report also provides the compound annual growth rate
(CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the
base year.

Transparency Market Research

Inhalation and Nasal Spray

Generic Drugs Market

Enquiry Before Buying:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1922
Geographically, the global inhalation and nasal spray generic drugs market has been categorized into six
major regions: North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of
the World. The market size and forecast for each of these regions has been provided for the period from
2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering
2014 as the base year. The research study also covers the competitive scenario in these regions. A
detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and
future opportunities has been provided in the market overview section. This section of the report also
provides market attractiveness analysis by drug class and geography, as well as market share analysis by
key players, thus presenting a thorough analysis of the overall competitive scenario in the global inhalation
and nasal spray generic drugs market.
Current and future trends has also been provided for new entrants as well as existing market players to
assist them in taking strategic initiatives to establish a strong presence in the market. The report also
profiles major players in the inhalation and nasal spray generic drugs market based on various attributes
such as company overview, financial overview, product portfolio, business strategies, and recent
developments. Major players profiled in this report include Teva Pharmaceutical Industries Ltd., Sandoz
International GmbH (Novartis AG), Allergan plc, Mylan N.V., Ranbaxy Laboraotries Ltd., Roxane
Laboratories, Inc., Beximco Pharmaceuticals Ltd., Cipla Ltd., and Nephron Pharmaceuticals Corporation.
Browse Full Press Release @
http://www.transparencymarketresearch.com/pressrelease/inhalation-nasal-spray-generic-drugs.htm

TABLE OF CONTENT

1. Preface
1.1. Report Description

Transparency Market Research

Inhalation and Nasal Spray

Generic Drugs Market

1.2. Market Segmentation

1.3. Research Methodology
2. Executive Summary
2.1. Global Inhalation and Nasal Spray Generic Drugs Market Revenue, 20132023 (US$ Mn)
2.2. Global Inhalation and Nasal Spray Generic Drugs Market Revenue, by Drug Class, 2014 (US$ Mn)
2.3. Global Inhalation and Nasal Spray Generic Drugs Market Revenue, by Medical Indication, 2014 (US$
Mn)
2.4. Global Market Share by Geography, 2014 and 2023 (Value %)
2.5. Inhalation and Nasal Spray Generic Drugs Market Snapshot
3. Global Inhalation and Nasal Spray Generic Drugs Market Industry Analysis
3.1. Introduction
3.2. Drivers
3.2.1. Rise in incidence of asthma, COPD, and other respiratory diseases to provide an impetus for
growth
3.2.2. Low cost involved with generic prescription drugs
3.3. Restraints
3.3.1. Stringent regulatory policies for generic drugs in developing countries
3.1. Opportunities
3.1.1. Patent expiry of blockbuster drugs would provide new opportunities for generic drug
manufacturers
3.2. Market Attractiveness Analysis Inhalation and Nasal Spray Generic Drugs Market, By Drug Class
3.3. Market Attractiveness Analysis Inhalation and Nasal Spray Generic Drugs Market, By Geography
3.4. Company Market Share Inhalation and Nasal Spray Generic Drugs Market (2014) (%)
3.5. Patient Pool Analysis, by Medical Indication

Transparency Market Research

Inhalation and Nasal Spray

Generic Drugs Market

3.6. Regulatory Framework for U.S.

3.7. Regulatory Framework for Europe
4. Market Segmentation By Drug Class
4.1. Introduction
4.2. Global Corticosteroids Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.2.1. Global Fluticasone Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.2.2. Global Budesonide Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.2.3. Global Beclomethasone Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$
Mn)
4.2.4. Global Flunisolide Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.2.5. Global Other Corticosteroids Market for Inhalation and Nasal Spray Generic Drugs, 20132023
(US$ Mn)
4.3. Global Bronchodilators Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.3.1. Global Albuterol Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.3.2. Global Epinephrine Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.3.3. Global Other Bronchodilators Market for Inhalation and Nasal Spray Generic Drugs, 20132023
(US$ Mn)
4.4. Global Antihistamines Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.5. Global Combinations Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$ Mn)
4.5.1. Global Salmeterol/Fluticasone Market for Inhalation and Nasal Spray Generic Drugs, 2013
2023 (US$ Mn)
4.5.2. Global Formoterol/Budesonide Market for Inhalation and Nasal Spray Generic Drugs, 2013
2023 (US$ Mn)
4.5.3. Global Azelastine/Benzalkonium Chloride Market for Inhalation and Nasal Spray Generic Drugs,
20132023 (US$ Mn)

Transparency Market Research

Inhalation and Nasal Spray

Generic Drugs Market

4.5.4. Global Other Combination Drugs Market for Inhalation and Nasal Spray Generic Drugs, 2013
2023 (US$ Mn)
4.6. Global Decongestant Sprays Market for Inhalation and Nasal Spray Generic Drugs, 20132023 (US$
Mn)
4.6.1. Global Phenylephrine Hydrochloride Market for Inhalation and Nasal Spray Generic Drugs,
20132023 (US$ Mn)
4.6.2. Global Oxymetazoline Hydrochloride Market for Inhalation and Nasal Spray Generic Drugs,
20132023 (US$ Mn)
5. Market Segmentation By Medical Indication
5.1. Introduction
5.2. Global Inhalation and Nasal Spray Generic Drugs Market for Asthma, 20132023 (US$ Mn)
5.3. Global Inhalation and Nasal Spray Generic Drugs Market for COPD, 20132023 (US$ Mn)
5.4. Global Inhalation and Nasal Spray Generic Drugs Market for Allergic Rhinitis, 20132023 (US$ Mn)
5.5. Global Inhalation and Nasal Spray Generic Drugs Market for Other Respiratory Disorders, 20132023
(US$ Mn)
6. Inhalation and Nasal Spray Generic Drugs Market - Regional Analysis
6.1. Global Inhalation and Nasal Spray Generic Drugs Market: Regional Overview
6.2. North America Inhalation and Nasal Spray Generic Drugs Market Overview
6.3. Europe Inhalation and Nasal Spray Generic Drugs Market Overview
6.4. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Overview
6.5. Latin America Inhalation and Nasal Spray Generic Drugs Market Overview
6.6. Middle East and North Africa Inhalation and Nasal Spray Generic Drugs Market Overview
6.7. RoW Inhalation and Nasal Spray Generic Drugs Market Overview
7. Historical Snapshot and Current Trends
8. Company Profiles.

Transparency Market Research

Inhalation and Nasal Spray

Generic Drugs Market

8.1. Allergan plc

8.2. Beximco Pharmaceuticals
8.3. Cipla Ltd.
8.4. Mylan N.V.
8.5. Nephron Pharmaceuticals Corporation
8.6. Ranbaxy Laboratories Ltd.
8.7. Roxane Laboratories, Inc.
8.8. Sandoz International GmbH (Novartis AG)
8.9. Teva Pharmaceutical Industries Ltd.

About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research,
and consulting services. TMRs global and regional market intelligence coverage includes industries such
as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer
goods, among others. Each TMR research report provides clients with a 360-degree view of the market with
statistical

forecasts,

competitive

landscape,

detailed

segmentation,

key

trends,

recommendations.

Contact

Transparency Market Research

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Transparency Market Research

and

strategic